Opioids interfere with cancer immunotherapy, but another type of drug could help
Opioids are often first-line treatments for cancer-related pain, but they can suppress the immune system and reduce the ...
Taiwan News25 天
North American & European Methylnaltrexone Market to Hit $12.7M by 2031 at 4.9% CAGR
Astute Analytica has released a comprehensive report titled North American & European Methylnaltrexone Market – Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032. This ...
JD Supra1 个月
ANDA Approvals - New Drug Applications and 505(b)(2) Applications: Third Quarter
DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on ...
Too Old to Operate1 个月
Impact of Methylnaltrexone on AP Severity and Pain Management
The following is a summary of “No Effect of Methylnaltrexone on Acute Pancreatitis Severity: A Multicenter Randomized Controlled Trial,” published in the November 2024 issue of Gastroenterology by ...
Medscape2 年
Subcutaneous Methylnaltrexone for Treatment of Acute Opioid-induced Constipation
This pilot study suggests that methylnaltrexone actively induces laxation and is generally well tolerated in patients receiving mu-opioid analgesia, following orthopedic surgery, who develop OIC ...
Medscape12 年
Subcutaneous Methylnaltrexone for Treatment of Acute Opioid-induced Constipation
Background: Methylnaltrexone has been shown to be effective for treating opioid-induced constipation (OIC) in chronic settings, but its effects on acute OIC have not been studied. Objective ...